MARKET WIRETradingView • 12h ago
AirSculpt Technologies, Inc. Estimates – NASDAQ:AIRSTradingView report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
Why AIRS Stock surged +3.59% Today — RQD Quant Desk Flash
$1.73 +3.59% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.74
AirSculpt Technologies Inc. (AIRS) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $120.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on AIRS Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is AIRS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, AirSculpt Technologies Inc. (NASDAQ: AIRS) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.73 (+3.59% 1D, market cap $120.4M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, AIRS ranks #747 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does AIRS compare to NAKA and LFMD in the Health Care sector?
▼
Within the Health Care sector (Medical/Nursing Services), AIRS carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -7.0%. By comparison, NAKA (Nakamoto Inc.) holds a E grade (18/100 RQD, P/E N/A, ROIC -31.6%, cap $126.2M) and LFMD (LifeMD Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -26.2%, cap $111.8M). Among the 5-stock peer group, AIRS leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for AIRS?
▼
Per AIRS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001870940), AirSculpt Technologies Inc. generated $151.8M in revenue (-15.8% YoY), -$11.7M in net income, and $692.0K in free cash flow against $187.3M in total assets and $50.6M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.74 (+0.46%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.5% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-11% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AIRS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY AIRS SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+9/20 pts (27% of score)
SEC XBRL FY 2025 (10-K): 0.5% FCF Margin ($692.0K FCF) & 52% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (24% of score)
Altman Z-Score 0.95 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$1.63-23.3% Next Q
25
Q2 (-2Q)Grade E$1.25-6.4% Next Q
28
Q3 (-1Q)Grade E$1.17+47.9% Next Q
30
CurrentGrade E$1.73-8.9% Hist 90D α
33
Trajectory: E (25) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a AIRS Turnaround Squeeze
While AIRS currently carries a cautious 33/100 (E) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.98) and Max Pain ($1.82) forces dealer call-delta covering toward $11.73.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $AIRS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “AIRS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why AIRS Stock surged +3.59% Today — RQD Quant Desk Flash
AirSculpt Technologies Inc. (AIRS) surged +3.59% to $1.73, trading at 6% of its 52-week range ($1.15 – $11.17). Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 6% of its 52-week range ($1.15 – $11.17) with RSI-14 at 50.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.73 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $692000 annual free cash flow.
Live AIRS Headlines & Catalysts
MARKET WIREThe Globe and Mail • 15h ago
Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS)The Globe and Mail report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo! Finance Canada • 18h ago
AirSculpt Technologies, Inc. (AIRS) Seasonal Returns ChartYahoo! Finance Canada report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMarketBeat • 21h ago
AirSculpt Technologies (AIRS) Projected to Announce Quarterly Earnings on MondayMarketBeat report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
Two Thrivent entities report the same 3.59M Airsculpt Technologies (AIRS) shares.Stock Titan report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
CATALYSThttps://www.dars.gov.et/ • 1d ago
AirSculpt Technologies (AIRS) Slips 2.11% to $1.62 as Shares Press Against Nearby Support - AAII Bullishhttps://www.dars.gov.et/ report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMarketBeat • 1d ago
AirSculpt Technologies (NASDAQ:AIRS) Coverage Initiated by Analysts at Lake Street CapitalMarketBeat report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
High Dividend Yield Stocks for IncomeTradingKey report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 6h ago
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it wi
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AIRS)
- ✓Walkthrough of AIRS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
AIRS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -49.71%▼ DESCENDING CHANNEL
2026-11-02O $1.44H $1.73L $1.44C $1.73VOL 1.55M
RES: $4.40SUP: $0.77SMA50: $1.98SMA200: $3.12
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
AIRS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -15.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on AIRS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for AIRS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AIRS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AIRS)
Health Care Rank #747 of 1016
⚔️ NAKA vs AIRS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (AIRS vs. NAKA, LFMD, ALPS, EUDA)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, AirSculpt Technologies Inc. (AIRS) ranks #747 by composite RQD confidence (33/100, grade E) and #635 by equity capitalization ($120.4M). Within this direct 5-issuer industry benchmark cohort, AIRS leads on earnings valuation at N/A trailing P/E, while AIRS leads on capital efficiency and profitability with -7.0% ROIC and — gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with AIRS at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AIRS
ACTIVE
AirSculpt Technologies Inc. | E | 33/100 | — | — | -7.0% | +3.59% | $120.4M | Benchmark Subject |
| NAKA Nakamoto Inc. | E | 18/100 | — | — | -31.6% | -14.83% | $126.2M | /naka-vs-airs → |
| LFMD LifeMD Inc. | E | 32/100 | — | 85.7% | -26.2% | -1.29% | $111.8M | /lfmd-vs-airs → |
| ALPS ALPS Group Inc Ordinary Share | D | 50/100 | — | — | — | +0.03% | $54.1M | /alps-vs-airs → |
| EUDA EUDA Health Holdings Limited | D- | 35/100 | — | 43.9% | -35.0% | +14.19% | $46.4M | /euda-vs-airs → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001870940In its most recent audited fiscal period (FY2025, filed 2025-12-31), AirSculpt Technologies Inc. (AIRS) reported GAAP revenue of $151.8M (-15.8% vs. FY2024 revenue of $180.3M , and -22.5% cumulative change since FY2023) , GAAP net income of -$11.7M, operating cash flow of $3.1M, and free cash flow of $692.0K (+126.0% YoY). On the balance sheet, AIRS closed FY2025 with $187.3M in total assets against $50.6M in total debt (Altman Z-Score: 0.95, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $151.8M | -$11.7M | $3.1M | $692.0K | $187.3M | $50.6M |
| FY2024 (FY) | 2024-12-31 | $180.3M | -$8.0M | $11.3M | -$2.7M | $212.8M | $65.5M |
| FY2023 (FY) | 2023-12-31 | $195.9M | -$4.2M | $24.0M | $24.0M | — | — |
3. AIRS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs AIRS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, AirSculpt Technologies Inc. (NASDAQ: AIRS) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.73 (+3.59% 1D, market cap $120.4M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, AIRS ranks #747 in composite RQD confidence.
How does AIRS compare to NAKA and LFMD in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), AIRS carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -7.0%. By comparison, NAKA (Nakamoto Inc.) holds a E grade (18/100 RQD, P/E N/A, ROIC -31.6%, cap $126.2M) and LFMD (LifeMD Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -26.2%, cap $111.8M). Among the 5-stock peer group, AIRS leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for AIRS?
Per AIRS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001870940), AirSculpt Technologies Inc. generated $151.8M in revenue (-15.8% YoY), -$11.7M in net income, and $692.0K in free cash flow against $187.3M in total assets and $50.6M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is AIRS trading relative to its 50-day, 200-day, and 52-week technical levels?
AIRS last traded at $1.73 (+3.59% on volume of 749,295 shares), positioning the stock -12.63% below its 50-day simple moving average ($1.98) and -44.55% below its 200-day simple moving average ($3.12). Across its 52-week range of $1.15 to $11.17, AIRS sits at the 5.8% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.51 to $1.95).
AIRS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AIRS stock moving today?
Why AIRS Stock surged +3.59% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 33/100 (E)
✓ STAGE-C NUMBER FIREWALL VERIFIED
AIRS — AirSculpt Technologies Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:43:24Z
Roarable Rating Brief: What This Means to a Prospective Investor
The Roarable RQD Score is 33, graded E, with the verdict "Roarable Strong Sell — Forensic Risk / Avoid" per the Roarable RQD rating. Across the five pillars:
- Fundamental Cash Engine (9 / 20): Per the Roarable RQD rating, this pillar reflects ROIC of -7% and an FCF yield of 0.57%. For a prospective investor, this indicates the business is not currently generating meaningful returns on invested capital, and the cash yield offers little valuation support at the current price.
- Whale 13F Flow (5 / 20): Per the Roarable RQD rating, this pillar measures institutional accumulation and options positioning. The score is weak, and no holder-level detail is supplied in the source data, so the investor cannot verify whether institutions are building or reducing positions.
- Insider Conviction (5 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The low score signals limited evidence of insider conviction; the source data contains no transaction-level detail to test this further.
- Macro Regime Fit (6 / 20): Per the Roarable RQD rating, Beta is 1.0 with sector sensitivity considered. A beta of 1.0 means the stock is expected to move in line with the broad market, offering no defensive cushion from a market-level pullback.
- Forensic Balance Sheet (8 / 20): Per the Roarable RQD rating, the Altman Z-Score is 0.95, the Piotroski F-Score is 4/9, and Debt/Equity is 0.58. These readings point to elevated financial distress risk and weak fundamental quality.
Taken together, the pillars describe a stock with negative returns on capital, thin cash generation, weak signals from institutions and insiders, and a forensic profile that flags distress. Upside drivers would need to come from a turnaround in operating economics that the current data does not yet show. Valuation tradeoffs are sharp: the price of 1.67 sits against a 52-week range of $1.15 - $11.17, and earnings-based multiples are unavailable, so the investor cannot anchor value to earnings.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $151.8M | $-11.6M | $-11.7M | N/A | $0.7M | $8.4M | $50.6M |
| FY 2024 | $180.3M | $-1.6M | $-8.0M | N/A | $-2.7M | $8.2M | $65.5M |
| FY 2023 | $195.9M | $9.7M | $-4.2M | N/A | $24.0M | N/A | N/A |
Per the SEC financials, revenue declined across the three reported periods, and net income was negative in each. Per the market data, the operating margin is -7.6%, the net margin is -7.7%, and the gross margin is 0%. ROIC is -7% per the market data. Per the Roarable RQD rating, the Altman Z-Score is 0.95, the Piotroski F-Score is 4/9, and Debt/Equity is 0.58. Reported debt fell from $65.5M in FY 2024 to $50.6M in FY 2025, while cash was $8.4M at FY 2025.
Open Questions
- What are the company's reported EPS and P/E figures, given that EPS (TTM) and earnings multiples are absent?
- What drove the decline in revenue from $195.9M in FY 2023 to $151.8M in FY 2025, and is it expected to stabilize?
- What is the composition of the institutional and insider holder base, given that holders data is absent?
- What is the status of the debt reduction from $65.5M to $50.6M, and what are the refinancing terms?
- What is the basis for the price-action item's technical "support" characterization, and how does it square with the forensic distress readings?
AIRS Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for AirSculpt Technologies Inc. (AIRS) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE TradingView • 12h ago
AirSculpt Technologies, Inc. Estimates – NASDAQ:AIRS TradingView report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE The Globe and Mail • 15h ago
Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC) and Airsculpt Technologies (AIRS) The Globe and Mail report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo! Finance Canada • 18h ago
AirSculpt Technologies, Inc. (AIRS) Seasonal Returns Chart Yahoo! Finance Canada report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE MarketBeat • 21h ago
AirSculpt Technologies (AIRS) Projected to Announce Quarterly Earnings on Monday MarketBeat report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
Two Thrivent entities report the same 3.59M Airsculpt Technologies (AIRS) shares. Stock Titan report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST https://www.dars.gov.et/ • 1d ago
AirSculpt Technologies (AIRS) Slips 2.11% to $1.62 as Shares Press Against Nearby Support - AAII Bullish https://www.dars.gov.et/ report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE MarketBeat • 1d ago
AirSculpt Technologies (NASDAQ:AIRS) Coverage Initiated by Analysts at Lake Street Capital MarketBeat report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
High Dividend Yield Stocks for Income TradingKey report covering AirSculpt Technologies Inc. (AIRS) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
AIRS Bull vs. Bear Conversation Board — What's Your Call at $1.73?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AIRS 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $1.47 (-12.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is AIRS (E • RQD 33/100) a Buy at $1.67?
Welcome to the AIRS (AirSculpt Technologies Inc.) Roar Pit. Current RQD Composite is 33/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Medical/Nursing Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
FO ForensicBear Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $1.35 (-19.2%)
Spot @ $1.67 Pump the brakes on AIRS — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on AIRS, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless AirSculpt Technologies Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
MI MidwestValue Verified K Arena Trader 🐂 BULLISH
🎯 Target: $1.95 (+16.8%)
Spot @ $1.67 AIRS cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on AIRS, the market is fixating on short-term headline noise in Medical/Nursing Services and ignoring the balance sheet and cash flow trajectory. At $1.67 (52-wk range $1.15 - $11.17), any beat on forward guidance forces shorts and underweight funds to chase.